Mangrove Partners’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
Sell
-195,308
Closed -$20.1M 227
2023
Q2
$20.1M Buy
+195,308
New +$20.1M 1.39% 25